10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2015

Filing Information

Form Type	10-Q
Accession Number	`0001213900-15-001037`
Period End Date	20141231
Filing Date	20150213
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	relm-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 44 Cash Flow Statement 65

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$178.16K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.34M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.74M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$32.76M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$23.51K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$9.84K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	53.68M	shares	Point-in-time
Other assets	`OtherAssets`	$12.10K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.29M	shares	Point-in-time
Other assets	`OtherAssets`	$12.10K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.29M	shares	Point-in-time
Total assets	`Assets`	$32.79M	USD	Point-in-time
Total assets	`Assets`	$25.76M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	53.68M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$969.95K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.10K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$521.68K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$382.02K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$58.36K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$38.09K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$25.59M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$26.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.77M	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$100.00K	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$100.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$26.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$28.20M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, Value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, Value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 500,000,000 shares authorized, 53,681,045 and 40,294,217 shares issued and outstanding, respectively	`CommonStockValue`	$40.29K	USD	Point-in-time
Common stock, $0.001 par value, 500,000,000 shares authorized, 53,681,045 and 40,294,217 shares issued and outstanding, respectively	`CommonStockValue`	$53.68K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$84.24M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$54.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-55.32M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$4.59M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$32.79M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$25.76M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$-4.27M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$-4.54M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$-2.09M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$-2.81M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-2.29M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$-5.30M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-996.90K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-789.44K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$-5.06M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$-4.38M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$-5.54M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$-8.11M	USD	2 Qtrs
Other Income (expenses)	`OperatingIncomeLoss`	$-4.38M	USD	1 Quarter
Other Income (expenses)	`OperatingIncomeLoss`	$-5.54M	USD	2 Qtrs
Other Income (expenses)	`OperatingIncomeLoss`	$-5.06M	USD	1 Quarter
Other Income (expenses)	`OperatingIncomeLoss`	$-8.11M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$9.84M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-1.02M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-16.28M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$7.22K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.11K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	$111.63K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.10K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.37K	USD	2 Qtrs
Interest expense	`InterestExpense`	$178.64K	USD	2 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-16.28M	USD	2 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-1.20M	USD	2 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$-111.63K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$9.84M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$5.46M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-24.38M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-6.73M	USD	2 Qtrs
Net Income (Loss)	`NetIncomeLoss`	$-5.17M	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-2.10	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-0.53	USD	2 Qtrs
Net Income (Loss) per common share - basic	`EarningsPerShareBasic`	$-2.74	USD	2 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-0.53	USD	2 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-2.10	USD	1 Quarter
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$-2.74	USD	2 Qtrs
Net Income (Loss) per common share - diluted	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$5.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.73M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.17M	USD	1 Quarter
Depreciation expense	`Depreciation`	$3.50K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$373.00	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$-999.58K	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$-3.77M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$382.34K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$356.27K	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$16.28M	USD	2 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$1.02M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$87.48K	USD	2 Qtrs
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$44.92K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-3.17K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$923.87K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$78.20K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$223.86K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$139.66K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$522.98K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.31M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-829.28K	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$17.17K	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$8.87K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.87K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.17K	USD	2 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	$13.43M	USD	2 Qtrs
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$255.54K	USD	2 Qtrs
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.30M	USD	2 Qtrs
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	2 Qtrs
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	-	USD	2 Qtrs
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	$501.60K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.18M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.80M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$5.85M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$1.96M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$31.42M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$31.42M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Interest	`InterestPaid`	$4.37K	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$293.62K	USD	2 Qtrs
Cancellation of note payable for insurance premiums	`CancellationOfNotePayable`	$55.22K	USD	2 Qtrs
Reclassification of warrant liabilities to additional paid in capital for warrant exercises	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Reclassification of warrant liabilities to additional paid in capital for warrant exercises	`FairValueAdjustmentOfWarrants`	$15.30M	USD	2 Qtrs
Conversion of Series A Preferred stock to common stock	`ConversionOfSeriesAPreferredStockToCommonStock`	$2.87K	USD	2 Qtrs
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	-	USD	2 Qtrs
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	$1.16M	USD	2 Qtrs
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	$83.36K	USD	2 Qtrs
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	-	USD	2 Qtrs
Fair value of warrants issued in connection with deferred financing costs	`FairValueOfWarrantsIssuedInConnectionWithDeferredFinancingCosts`	-	USD	2 Qtrs
Fair value of warrants issued in connection with deferred financing costs	`FairValueOfWarrantsIssuedInConnectionWithDeferredFinancingCosts`	$41.68K	USD	2 Qtrs
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	$163.62K	USD	2 Qtrs
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.